copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Homepage | Fintepla HCP Learn about FINTEPLA®, a treatment for seizures associated with Dravet syndrome and LGS, and get full Prescribing Information, including Boxed Warning
FINTEPLA® (fenfluramine) | Official Patient Website FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
Fenfluramine - Epilepsy Foundation Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix
Fintepla (fenfluramine): Uses, Side Effects, Dosage Reviews Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions Fintepla (fenfluramine) comes as an oral solution, so it's a good option for people who can't swallow pills
Fintepla (fenfluramine) - Uses, Side Effects, and More Overview: Fintepla is used to treat certain types of seizures It may work by blocking certain signals that come from nerves and cause seizures Common side effects include weight loss, sleepiness
Understanding Fintepla: What It Is and How It Works for Epilepsy Fintepla, or fenfluramine, is an FDA-approved medication for managing seizures in Dravet syndrome, a severe epilepsy form primarily affecting infants and young children It acts as a serotonin-releasing agent, enhancing serotonin levels in the brain to stabilize neuronal excitability and reduce seizure frequency Indicated for patients aged two and older, especially those unresponsive to other
DailyMed - FINTEPLA- fenfluramine solution FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older
FINTEPLA® Prescriber Resources | FINTEPLA (fenfluramine) oral . . . Download FINTEPLA® resources for your practice In the randomized, double-blind, placebo-controlled trial of FINTEPLA in LGS, the primary endpoint was the change in frequency of the following seizure types that were confirmed by The Epilepsy Study Consortium to have resulted in a drop, fall, or injury: generalized tonic-clonic (GTC), secondarily GTC, tonic, atonic, and tonic-atonic